Delivery Order SPE2DB22D1202-SPE2DB25FUXS9
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML pharmaceutical products. The fixed-price delivery order, valued at $5,973.29, has an ultimate completion date of October 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,833.18, is for the delivery of PROVAYBLUE 50 MG/10 ML AMPULE 10ML medical supplies. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,415.97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of PROVAYBLUE 50 MG/10 ML VIAL 10ML pharmaceutical product. The contract has a ceiling value of $1,415.97 and an ultimate completion date of August 6, 2024. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROVAYBLUE 50 MG/10 ML AMPULE 10ML medical products. The award has a ceiling value of $6,827.92 and a completion date of February 6, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,525.62 firm fixed-price delivery order contract is for the supply of "PROVAYBLUE 50 MG/10 ML AMPULE 10ML" and has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,399.56, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The IDC enables efficient government procurement of essential pharmaceutical and medical supplies to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,645.71, is a Firm Fixed Price Delivery Order for the pharmaceutical product "PROVAYBLUE 50 MG/10 ML AMPULE 10ML". The contract has an ultimate completion date of March 4, 2024 and was awarded on March 1, 2024. There is no set-aside designation mentioned for this award....
This federal contract award is for the delivery of Provayblue 50 mg/10 ml ampules to the Defense Logistics Agency (DLA). The contract, valued at $2,747.82, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Provayblue 50 mg/10 ml vial. The contract has a ceiling value of $1,253.40 and a performance period extending through April 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a $45,053.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a medical product. The award is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...